Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May;74(5):907-15.
doi: 10.1016/j.jaad.2015.11.044. Epub 2016 Jan 16.

The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs)

Jung Min Bae  1 , Bo Young Hong  2 , Joo Hee Lee  3 , Ji Hae Lee  3 , Gyong Moon Kim  4
Affiliations
Review

The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs)

Jung Min Bae et al. J Am Acad Dermatol. 2016 May.

Abstract

Background: Combination therapies of excimer laser/light (EL) and various topical agents are widely used in the treatment of vitiligo.

Objective: We sought to compare the efficacy of EL and topical agent combination therapy versus EL monotherapy for vitiligo.

Methods: Manual searches of reference lists and computerized searches of the MEDLINE, EMBASE, and Cochrane library (from inception through December 15, 2014) were conducted to identify randomized controlled trials that assessed the efficacy of EL alone or in combination with topical agents for vitiligo. The primary outcome was treatment success (≥75% repigmentation), and the secondary outcome was treatment failure (<25% repigmentation); meta-analyses were performed when possible.

Results: We analyzed 8 randomized controlled trials comprising a total of 425 patches/patients. The combination of EL and topical calcineurin inhibitors (4 studies: relative risk 1.93, 95% confidence interval 1.28-2.91; number needed to treat 4.5, 95% confidence interval 2.9-10) was superior to EL monotherapy for vitiligo. There was insufficient evidence to support beneficial effects of topical vitamin-D3 analogs (3 studies) and corticosteroids (1 study).

Limitations: These findings are based on small numbers of randomized controlled trials and heterogeneities among included studies are another limitation.

Conclusion: Topical calcineurin inhibitors in conjunction with EL are more effective compared with EL monotherapy.

Keywords: excimer laser; laser; pimecrolimus; tacrolimus; topical calcineurin inhibitor; vitiligo.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Substances